Fiona Powrie

Last updated

Dame Fiona Powrie
Professor Fiona Powrie.jpg
Born1963 (age 5859)
Luton, England [1]
Alma mater
Known forWork on Regulatory T Cells
Awards
Academic career
Institutions
  • DNAX Research Institute
  • The Kennedy Institute of Rheumatology (University of Oxford)
Thesis Functional analysis of rat T cell subsets
Doctoral advisor Don Mason
Academic advisor Robert L. Coffman

Dame Fiona Magaret Powrie DBE FRS FMedSci (born 1963) is currently the head of the Kennedy Institute of Rheumatology at the University of Oxford. [2] Formerly she was the inaugural Sidney Truelove Professor of Gastroenterology at the University of Oxford. She is also head of the Experimental Medicine Division of the Nuffield Department of Clinical Medicine. [3]

Contents

Career

Powrie studied biochemistry at the University of Bath, [4] before completing a D. Phil. in Don Mason's lab at the Sir William Dunn School of Pathology, the University of Oxford. [5]

Notable work

Regulatory T cells

Powrie worked with Don Mason at the Sir William Dunn School of Pathology studying the interactions of different subsets of CD4+ T cells in rats. This work identified that CD4+OX22hi (OX22 is CD45RC in rats and the equivalent of CD45RB in mice, both isoforms of CD45 [6] ) T cells contained pathogenic activity while CD4+OX22lo T cells contained regulatory activity and could prevent the pathogenic activity of CD4+OX22hi T cells [7] These were foundational studies and represented some of the seminal work on regulatory T cells (Treg).

Intestinal inflammation

Powrie performed post-doctoral studies with Robert L. Coffman at DNAX in Palo Alto, California. Here, she extended her earlier work in rats to mice and developed the "T cell transfer" model, one of the most prominent models of intestinal inflammation where transfer of CD4+CD45RBhi T cells to Rag deficient or SCID mice led to the development of severe intestinal inflammation and wasting disease. This could be prevented by transfer of CD4+CD45RBlo T cells. [8] Using this model Powrie further identified the pathogenic role played by IFN-γ and TNF-α in intestinal inflammation and the therapeutic potential of IL-10 [9] and highlighted the requirement for TGF-β in the prevention of colitis by the CD4+CD45RBlo regulatory T cell subset [10] Upon returning to the University of Oxford in 1996, first to the Nuffield Department of Surgery and later, the Sir William Dunn School of Pathology, Powrie used the T cell transfer model to identify the suppressive mechanisms used by regulatory T cells to prevent intestinal inflammation including the requirements for CTLA-4 [11] and the capacity of Treg to prevent colitis driven by innate immune cells as well as CD4+ T cells. [12] Focusing on pathogenic mechanisms the Powrie lab. identified the critical role played by the cytokine IL-23 in driving pathology in the intestine [13]

Therapeutic potential of Tregs

Work from the Powrie lab. identified that Treg could not alone prevent inflammatory bowel disease but could actually cure established inflammation. [14] Furthermore, Powrie was among the first to identify a population of CD4+CD25+ T cells in human peripheral blood that possessed regulatory capacity, confirming these cells as a bona fide T cell subset in humans. [15]

Honours and awards

In 2009, Powrie was appointed as the inaugural Sidney Truelove Professor of Gastroenterology within the Nuffield Department of Clinical Medicine in Oxford. [3] She was elected a Fellow of the Royal Society in 2011, [16] and was awarded the Louis-Jeantet Prize for Medicine in 2012. [17]

Powrie was appointed Dame Commander of the Order of the British Empire (DBE) in the 2022 Birthday Honours for services to medical science. [18]

Related Research Articles

<span class="mw-page-title-main">Interleukin 10</span> Anti-inflammatory cytokine

Interleukin 10 (IL-10), also known as human cytokine synthesis inhibitory factor (CSIF), is an anti-inflammatory cytokine. In humans, interleukin 10 is encoded by the IL10 gene. IL-10 signals through a receptor complex consisting of two IL-10 receptor-1 and two IL-10 receptor-2 proteins. Consequently, the functional receptor consists of four IL-10 receptor molecules. IL-10 binding induces STAT3 signalling via the phosphorylation of the cytoplasmic tails of IL-10 receptor 1 + IL-10 receptor 2 by JAK1 and Tyk2 respectively.

The regulatory T cells (Tregs or Treg cells), formerly known as suppressor T cells, are a subpopulation of T cells that modulate the immune system, maintain tolerance to self-antigens, and prevent autoimmune disease. Treg cells are immunosuppressive and generally suppress or downregulate induction and proliferation of effector T cells. Treg cells express the biomarkers CD4, FOXP3, and CD25 and are thought to be derived from the same lineage as naïve CD4+ cells. Because effector T cells also express CD4 and CD25, Treg cells are very difficult to effectively discern from effector CD4+, making them difficult to study. Research has found that the cytokine transforming growth factor beta (TGF-β) is essential for Treg cells to differentiate from naïve CD4+ cells and is important in maintaining Treg cell homeostasis.

Dr George Gordon MacPherson was Reader in Experimental Pathology, Turnbull Fellow, Tutor in Medicine, and Senior Tutor at Oriel College, Oxford. He held a Bachelor's degree (B.M.), Master's degree (M.A.) and a doctorate (D.Phil.). His research interests were in Cell Biology, Pathology, and Immunology. Medically qualified, he researched in the field of cellular immunology at the Sir William Dunn School of Pathology, University of Oxford.

Immune tolerance, or immunological tolerance, or immunotolerance, is a state of unresponsiveness of the immune system to substances or tissue that would otherwise have the capacity to elicit an immune response in a given organism. It is induced by prior exposure to that specific antigen and contrasts with conventional immune-mediated elimination of foreign antigens. Tolerance is classified into central tolerance or peripheral tolerance depending on where the state is originally induced—in the thymus and bone marrow (central) or in other tissues and lymph nodes (peripheral). The mechanisms by which these forms of tolerance are established are distinct, but the resulting effect is similar.

<span class="mw-page-title-main">CD86</span>

Cluster of Differentiation 86 is a protein constitutively expressed on dendritic cells, Langerhans cells, macrophages, B-cells, and on other antigen-presenting cells. Along with CD80, CD86 provides costimulatory signals necessary for T cell activation and survival. Depending on the ligand bound, CD86 can signal for self-regulation and cell-cell association, or for attenuation of regulation and cell-cell disassociation.

<span class="mw-page-title-main">Intraepithelial lymphocyte</span>

Intraepithelial lymphocytes (IEL) are lymphocytes found in the epithelial layer of mammalian mucosal linings, such as the gastrointestinal (GI) tract and reproductive tract. Epithelium of small intestine contains approximately 1 IEL per 10 enterocytes. However, unlike other T cells, IELs do not need priming. Upon encountering antigens, they immediately release cytokines and cause killing of infected target cells. In the GI tract, they are components of gut-associated lymphoid tissue (GALT).

<span class="mw-page-title-main">ITGAE</span>

Integrin, alpha E (ITGAE) also known as CD103 is an integrin protein that in human is encoded by the ITGAE gene. CD103 binds integrin beta 7 to form the complete heterodimeric integrin molecule αEβ7, which has no distinct name. The αEβ7 complex is often referred to as "CD103" though this strictly refers only to the αE chain. Note that the β7 subunit can bind with other integrin α chains, such as α4 (CD49d).

T helper 17 cells (Th17) are a subset of pro-inflammatory T helper cells defined by their production of interleukin 17 (IL-17). They are related to T regulatory cells and the signals that cause Th17s to differentiate actually inhibit Treg differentiation. However, Th17s are developmentally distinct from Th1 and Th2 lineages. Th17 cells play an important role in maintaining mucosal barriers and contributing to pathogen clearance at mucosal surfaces; such protective and non-pathogenic Th17 cells have been termed as Treg17 cells.

Peripheral tolerance is the second branch of immunological tolerance, after central tolerance. It takes place in the immune periphery. Its main purpose is to ensure that self-reactive T and B cells which escaped central tolerance do not cause autoimmune disease. Peripheral tolerance prevents immune response to harmless food antigens and allergens, too. 

Interleukin 35 (IL-35) is a recently discovered anti-inflammatory cytokine from the IL-12 family. Member of IL-12 family - IL-35 is produced by wide range of regulatory lymphocytes and plays a role in immune suppression. IL-35 can block the development of Th1 and Th17 cells by limiting early T cell proliferation.

<span class="mw-page-title-main">Lymphocyte-activation gene 3</span>

Lymphocyte-activation gene 3, also known as LAG-3, is a protein which in humans is encoded by the LAG3 gene. LAG3, which was discovered in 1990 and was designated CD223 after the Seventh Human Leucocyte Differentiation Antigen Workshop in 2000, is a cell surface molecule with diverse biologic effects on T cell function. It is an immune checkpoint receptor and as such is the target of various drug development programs by pharmaceutical companies seeking to develop new treatments for cancer and autoimmune disorders. In soluble form it is also being developed as a cancer drug in its own right.

T helper 3 cells (Th3) are a subset of T lymphocytes with immunoregulary and immunosuppressive functions, that can be induced by administration of foreign oral antigen. Th3 cells act mainly through the secretion of anti-inflammatory cytokine transforming growth factor beta (TGF-β). Th3 have been described both in mice and human as CD4+FOXP3 regulatory T cells. Th3 cells were first described in research focusing on oral tolerance in the experimental autoimmune encephalitis (EAE) mouse model and later described as CD4+CD25FOXP3LAP+ cells, that can be induced in the gut by oral antigen through T cell receptor (TCR) signalling.

Donald W. Mason was a British immunologist and professor of immunology in the MRC Cellular Immunology Unit at the Sir William Dunn School of Pathology at the University of Oxford. Professor Mason is best known for his work on regulatory T cells and their role in preventing autoimmunity. His distinction was recognised by his election in 2017 to honorary life membership of the British Society for Immunology.

<span class="mw-page-title-main">Interleukin 23</span>

Interleukin 23 (IL-23) is a heterodimeric cytokine composed of an IL-12B (IL-12p40) subunit and an IL-23A (IL-23p19) subunit. IL-23 is part of the IL-12 family of cytokines. The functional receptor for IL-23 consists of a heterodimer between IL-12Rβ1 and IL-23R.

Innate lymphoid cells (ILCs) are the most recently discovered family of innate immune cells, derived from common lymphoid progenitors (CLPs). In response to pathogenic tissue damage, ILCs contribute to immunity via the secretion of signalling molecules, and the regulation of both innate and adaptive immune cells. ILCs are primarily tissue resident cells, found in both lymphoid, and non- lymphoid tissues, and rarely in the blood. They are particularly abundant at mucosal surfaces, playing a key role in mucosal immunity and homeostasis. Characteristics allowing their differentiation from other immune cells include the regular lymphoid morphology, absence of rearranged antigen receptors found on T cells and B cells, and phenotypic markers usually present on myeloid or dendritic cells.

Regulatory B cells represent a small population of B cells which participates in immunomodulations and in suppression of immune responses. These cells regulate the immune system by different mechanisms. The main mechanism is a production of anti-inflammatory cytokine interleukin 10 (IL-10). The regulatory effects of Bregs were described in various models of inflammation, autoimmune diseases, transplantation reactions and in anti-tumor immunity.

<span class="mw-page-title-main">Bronchus-associated lymphoid tissue</span>

Bronchus-associated lymphoid tissue (BALT) is a tertiary lymphoid structure. It is a part of mucosa-associated lymphoid tissue (MALT), and it consists of lymphoid follicles in the lungs and bronchus. BALT is an effective priming site of the mucosal and systemic immune responses.

<span class="mw-page-title-main">Type 3 innate lymphoid cells</span>

Type 3 innate lymphoid cells (ILC3) are immune cells from the lymphoid lineage that are part of the innate immune system. These cells participate in innate mechanisms on mucous membranes, contributing to tissue homeostasis, host-commensal mutualism and pathogen clearance. They are part of a heterogeneous group of innate lymphoid cells, which is traditionally divided into three subsets based on their expression of master transcription factors as well as secreted effector cytokines - ILC1, ILC2 and ILC3.

Tolerogenic dendritic cells are heterogenous pool of dendritic cells with immuno-suppressive properties, priming immune system into tolerogenic state against various antigens. These tolerogenic effects are mostly mediated through regulation of T cells such as inducing T cell anergy, T cell apoptosis and induction of Tregs. Tol-DCs also affect local micro-environment toward tolerogenic state by producing anti-inflammatory cytokines.

<span class="mw-page-title-main">Gwendalyn J. Randolph</span> American immunologist

Gwendalyn J. Randolph is an American immunologist, the Emil R. Unanue Distinguished Professor in the Department of Immunology and Pathology at Washington University in St. Louis, Missouri, where she is currently co-director of the Immunology Graduate Program. During her postdoctoral work, Randolph characterized monocyte differentiation to dendritic cells and macrophages and made advances in our understanding of dendritic cell trafficking and the fate of monocytes recruited to sites of inflammation. Her lab has contributed to the Immunological Genome Project by characterizing macrophage gene expression. Her work now focuses on the immunological mechanisms driving atherosclerosis and inflammatory bowel disease (IBD) by exploring lymphatic function and lipoprotein trafficking.

References

  1. "2012 Louis-Jeantet Prize for Medicine".
  2. "Powrie, Prof. Fiona Margaret, (born 1963), Director, Kennedy Institute of Rheumatology and Professor, Nuffield Department of Orthopaedics, Rheumatology and Muskuloskeletal Sciences, University of Oxford, since 2014; Fellow of Wadham College, Oxford, since 2014". Powrie, Prof. Fiona Margaret | WHO'S WHO & WHO WAS WHO. 2012. doi:10.1093/ww/9780199540884.013.255684.
  3. 1 2 "Nuffield Department of Clinical Medicine – Prof Fiona Powrie FRS". Ndm.ox.ac.uk. Archived from the original on 20 November 2012. Retrieved 15 November 2012.
  4. "Keynotes". 2012.the-embo-meeting.org. Retrieved 15 November 2012.
  5. "A delicate balance: Investigating intestinal inflammation « Wellcome Trust Blog". Wellcometrust.wordpress.com. 31 January 2012. Retrieved 15 November 2012.
  6. Saouid A, Seddon B, Heath V, Fowell D, Mason D (1996). "The physiological role of regulatory T cells in the prevention of autoimmunity: the function of the thymus in the generation of the regulatory T cell subset". Immunological Reviews. 149: 195–216. doi:10.1111/j.1600-065x.1996.tb00905.x. PMID   9005215. S2CID   40160832.
  7. Powrie F, Mason D (1990). "OX-22high CD4+ T cells induce wasting disease with multiple organ pathology: prevention by the OX-22low subset". Journal of Experimental Medicine. 172 (6): 1701–8. doi:10.1084/jem.172.6.1701. PMC   2188779 . PMID   2258700.
  8. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL (1993). "Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice". International Immunology . 5 (11): 1461–71. doi:10.1093/intimm/5.11.1461. PMID   7903159.
  9. Powrie F, Leach MW, Mauze S, Menon S, Caddle LB, Coffman RL (1994). "Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells". Immunity. 1 (7): 553–62. doi:10.1016/1074-7613(94)90045-0. PMID   7600284.
  10. Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL (1996). "A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells". Journal of Experimental Medicine. 183 (6): 2669–74. doi:10.1084/jem.183.6.2669. PMC   2192626 . PMID   8676088.
  11. Read S, Malmstrom V, Powrie F (2000). "Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation". Journal of Experimental Medicine. 192 (2): 295–302. doi:10.1084/jem.192.2.295. PMC   2193261 . PMID   10899916.
  12. Maloy KJ, Salaun L, Cahill R, Dougan G, Saunders NJ, Powrie F (2003). "CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms". Journal of Experimental Medicine. 197 (1): 111–9. doi:10.1084/jem.20021345. PMC   2193798 . PMID   12515818.
  13. Hue S, Ahern P, Buonocore S, Kullberg MC, Cua DJ, McKenzie BS, Powrie F, Maloy KJ (2006). "Interleukin-23 drives innate and T cell-mediated intestinal inflammation". Journal of Experimental Medicine. 203 (11): 2473–83. doi:10.1084/jem.20061099. PMC   2118132 . PMID   17030949.
  14. Mottet C, Uhlig HH, Powrie F (2003). "Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells". Journal of Immunology. 170 (8): 3939–43. doi: 10.4049/jimmunol.170.8.3939 . PMID   12682220.
  15. Stephens LA, Mottet C, Mason D, Powrie F (2001). "Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro". European Journal of Immunology. 31 (4): 1247–54. doi: 10.1002/1521-4141(200104)31:4<1247::AID-IMMU1247>3.0.CO;2-M . PMID   11298351.
  16. "Professor Fiona Margaret Powrie FRS". Royal Society. Retrieved 15 November 2012.
  17. "2012 Louis-Jeantet Prize for Medicine". Eurekalert.org. Retrieved 15 November 2012.
  18. "No. 63714". The London Gazette (Supplement). 1 June 2022. p. B9.